BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 26, 2005
View Archived Issues
GRN-163L suppresses human hepatoma growth in mice
Read More
Anticocaine antibody prevents death in a model of cocaine overdose
Read More
Eight-day oseltamivir dosing more effective than five-day against H5N1 influenza virus in mice
Read More
Farnesyltransferase inhibitors show promise for treating progeria
Read More
Nanobodies may substitute monoclonal antibodies
Read More
AVE-7688 reduces renal fibrosis in COL4A3-/- mice
Read More
AlphaRx completes development of vancomycin delivered with nanoparticle delivery platform
Read More
Alnylam Pharmaceuticals updates product pipeline
Read More
Xoma signs manufacture agreement for Cubist's HepeX-B biologic
Read More
Kereos raises funds to support clinical evaluation of MRI agents and therapeutics
Read More
Vion initiates solid tumor clinical development program with Cloretazine
Read More
Beta-2 adrenergic agonist carmoterol interacts positively with budesonide and tiotropium
Read More
Survival benefits of MEDI-522 in advanced melanoma patients
Read More
Ruboxistaurin improves renal function in patients with type 2 diabetes and nephropathy
Read More
Phase II data on rEV-131 in seasonal allergic rhinitis
Read More
Vyteris' Actyve transdermal drug delivery technology shows promise in phase I
Read More
Genaissance and Otsuka enter genetic markers research alliance
Read More
GSK's Zefix approved in Japan for HBV-associated cirrhosis
Read More
XTLbio licenses anti-HCV compounds and technology from VivoQuest
Read More
New therapeutic agents disclosed for respiratory disorders
Read More
Tripep advances alpha-HGA to phase I/II trial for HIV
Read More
Recent patents cover novel treatments for neurological disorders
Read More
Cipralex receives European approval for generalized anxiety disorder
Read More
Triglyceride reducing agents emerge from Esteve R&D
Read More
Studies reveal efficacy of Lanreotide Autogel in acromegaly patients
Read More